UTMD
insider transactionsUTAH MEDICAL PRODUCTS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·G
Principal Financial Officer
$3.3K
50 sh · $66.27
Own -6%
-
Grant·A
Principal Financial Officer
$0
500 sh
Own +10%
-
Other·G
Principal Financial Officer
$3.1K
50 sh · $62.75
Own -6%
-
Other·G
Director
$6.0K
100 sh · $60.34
Own -0%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | Koopman Brian | Other G | 50 | $3.3K |
| Oct 31, 2025 | Koopman Brian | Grant A | 500 | $0 |
| Sep 4, 2025 | Koopman Brian | Other G | 50 | $3.1K |
| Aug 25, 2025 | RICHINS PAUL O | Other G | 100 | $6.0K |
About UTMD insider trading
This page tracks insider transactions for UTAH MEDICAL PRODUCTS INC (UTMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.